5 hours ago
FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs
What's happening
SignalsMonitor is following this as a general story. The Hill and NBC News Top Stories are the outlets attached to this story. The first report grouped here was at 9 Nov 2026, 18:14 UTC. 2 material updates are listed in the timeline. The headline in use is “FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
The Food and Drug Administration (FDA) on Monday required pharmaceutical companies to warn patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes. Non-arteritic anterior ischemic optic neuropathy (NAION), often referred to as an…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by NBC News Top Stories
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
- Picked up by The Hill
Same story, different outlets
2 headlinesEach line is that outlet's headline. The article stays on the publisher's site.